Human health is experiencing several obstacles in the modern medical era, particularly cancer. As a result, the cancer therapeutic arsenal should be continually expanded with innovative small molecules that preferentially target tumour cells. In this study, we describe the development of two small molecule series (- and -) based on the 1-benzyl-5-bromoindolin-2-one scaffold that connected through a hydrazone linker to a 4-arylthiazole (-) or 4-methyl-5-(aryldiazenyl)thiazole (-) moiety.
View Article and Find Full Text PDFIn the current work, we designed and synthesized three families of non-fused and fused compounds based on cyanopyridone: derivatives of 6-amino-1,2-dihydropyridine-3,5-dicarbonitrile () and 3,4,7,8-tetrahydro pyrimidine-6-carbonitrile ( and ). The newly synthesized compounds' structure were determined using a variety of techniques, including H NMR, C NMR, mass spectrum, infrared spectroscopy, and elemental analysis. The developed compounds were tested for the ability to inhibit the growth of breast adenocarcinoma (MCF-7) and hepatic adenocarcinoma (HepG2) cell lines using MTT assay.
View Article and Find Full Text PDFIn this work, different series of benzothiazole-based sulphonamides and carboxylic acids were developed as novel SLC-0111 analogues with the goal of generating potent carbonic anhydrase (CA) inhibitors. The adopted strategy involved replacing the 4-fluorophenyl tail in SLC-0111 with a benzothiazole motif that attached to the ureido linker to produce compounds and its regioisomers . In addition, the ureido spacer was elongated by methylene or ethylene groups to afford the counterparts and .
View Article and Find Full Text PDFDifferent 2,4-thiazolidinedione-tethered coumarins , and were synthesised and evaluated for their inhibitory action against the cancer-associated CAs IX and XII, as well as the physiologically dominant CAs I and II to explore their selectivity. Un-substituted phenyl-bearing coumarins , , and 2-thienyl/furyl-bearing coumarins exhibited the best CA IX (Ks between 0.48 and 0.
View Article and Find Full Text PDFSARS-CoV-2 (COVID-19), a novel coronavirus causing life-threatening pneumonia, caused a pandemic starting in 2019 and caused unprecedented economic and health crises all over the globe. This requires the rapid discovery of anti-SARS-CoV-2 drug candidates to overcome this life-threatening pandemic. Strawberry ( Duch.
View Article and Find Full Text PDFHuman health in the current medical era is facing numerous challenges, especially cancer. So, the therapeutic arsenal for cancer should be unremittingly enriched with novel small molecules that selectively target tumour cells with minimal toxicity towards normal cells. In this context, herein a new series of 3,6-disubstituted pyridazines has been synthesised and evaluated for anticancer activity.
View Article and Find Full Text PDFAs a continuation for our previous work, a novel set of -alkylindole-isatin conjugates (, , and ) is here designed and synthesised with the prime aim to develop more efficient isatin-based antitumor candidates. Utilising the SAR outputs from the previous study, our design here is based on appending four alkyl groups with different length (ethyl and n-propyl), bulkiness (iso-propyl) and unsaturation (allyl) on -1 of indole motif, with subsequent conjugation with different -unsubstituted isatin moieties to furnish the target conjugates. As planned, the adopted strategy achieved a substantial improvement in the growth inhibitory profile for the target conjugates in comparison to the reported lead .
View Article and Find Full Text PDFPursuing our effort for developing effective inhibitors of the cancer-related hCA IX isoform, here we describe the synthesis of novel benzofuran-based carboxylic acid derivatives, featuring the benzoic (-) or hippuric () acid moieties linked to 2-methylbenzofuran or 5-bromobenzofuran tails via an ureido linker. The target carboxylic acids were evaluated for the potential inhibitory action against hCAs I, II, IX, and XII. Superiorly, benzofuran-containing carboxylic acid derivatives , , and acted as submicromolar hCA IX inhibitors with KIs = 0.
View Article and Find Full Text PDF